Tampa drug company appoints two board members

Tampa-based Oragenics appointed Bruce Cassidy and John Gandolfo to its board of directors, the company says.

Oragenics is a development-stage company focused on nasal delivery of pharmaceutical medications including drugs involving neurological treatment, and drugs fighting infectious diseases including coronaviruses and multidrug-resistant organisms. Its lead product is NT-CoV2-1, an intranasal vaccine candidate to prevent COVID-19 and variants of coronavirus.

The Oragenics chairman says the pair will complement the board and company.